Skip to main content
TipRanks
Go Ultimate75% OFF

Aura (AURA) AI Stock Analysis

1 Followers
IL:AURA

Aura

(TASE:AURA)

Select Model
Rating:55Neutral
Price Target:ILA 1,717.00▼(-5.14% Downside)
Action:reiterated
Date:10/29/26

The score is held back primarily by weak cash generation and higher leverage, despite solid revenue growth and healthy margins. Technicals are also soft with the stock trading below major moving averages, while valuation is moderate with only a modest dividend yield.

Positive Factors
Revenue GrowthRevenue growth provides evidence of continued business expansion and stronger top-line activity. If maintained, this momentum can support operating scale, improve the company’s ability to absorb fixed costs, and create a broader base for sustaining profitability over the next several quarters.
Negative Factors
Rising LeverageThe sharp increase in debt-to-equity and absolute debt reduces financial flexibility and makes results more sensitive to funding conditions. Elevated leverage can constrain future investment, increase financing-related pressure, and leave the company less able to absorb operational or market setbacks.

Aura (AURA) vs. iShares MSCI Israel ETF (EIS)

-40%-30%-20%-10%0%10%20%30%40%IL:AURA-16.14%EIS+10.58%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
ILS 5.14B
Dividend Yield
1.07%
Average Volume (3M)
500.61K
Price to Earnings (P/E)
19.0
Beta (1Y)
1.74
Revenue Growth
47.76%
EPS Growth
-2.38%
Country
Israel
Employees
223
Sector
General
Sector Strength
55
Industry
Real Estate - Development

Aura Business Overview & Revenue Model

Company Description

Established in 1992 and based in Tel Aviv, Israel, Aura Investments Ltd. is an Israeli real estate firm dedicated to the conceptualization and execution of property developments. Its operations primarily involve the construction of new residential bu...

How the Company Makes Money

As a clinical-stage biotechnology company, Aura Biosciences has not publicly established recurring product revenue from commercialized therapies. Revenue, if any, is typically generated from non-commercial sources such as collaboration/licensing arra...

Aura Financial Statement Overview

Summary

Income statement strength (revenue up ~10.4% TTM with ~26% gross margin and ~12% net margin) is offset by rising leverage (debt-to-equity ~2.46 TTM) and persistently negative operating/free cash flow (about -1.0B TTM), increasing reliance on external financing.

Income Statement

78Positive

Balance Sheet

54Neutral

Cash Flow

28Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.24B1.90B1.52B1.04B849.01M893.89M
Gross Profit583.02M486.15M347.51M190.98M139.44M137.10M
EBITDA652.82M589.25M477.33M208.47M205.55M182.64M
Net Income269.89M280.75M360.14M117.69M140.54M113.53M
Balance Sheet
Total Assets8.45B7.87B4.88B3.14B2.60B1.86B
Cash, Cash Equivalents and Short-Term Investments530.83M663.97M137.03M129.36M73.21M67.45M
Total Debt4.12B3.32B2.26B1.36B845.63M828.08M
Total Liabilities6.51B6.00B3.59B2.24B1.93B1.34B
Stockholders Equity1.67B1.61B1.27B882.03M652.64M520.38M
Cash Flow
Free Cash Flow-1.01B-925.57M-127.40M-565.56M163.03M207.27M
Operating Cash Flow-1.00B-921.50M-122.29M-564.73M167.92M207.99M
Investing Cash Flow155.13M170.56M-412.89M-5.13M-141.69M-56.88M
Financing Cash Flow1.05B972.09M540.60M607.07M-26.42M-194.34M

Aura Technical Analysis

Technical Analysis SentimentPositive
Last Price1810.00

Price Trends

50DMA1765.61Positive
100DMA1714.81Positive
200DMA1905.03Negative

Market Momentum

MACD5.42Positive
RSI54.70Neutral
STOCH87.62Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AURA, the sentiment is Positive. The current price of 1810.00 is above the 20-day moving average (MA) of 1784.15, above the 50-day MA of 1765.61, and below the 200-day MA of 1905.03, indicating a neutral trend. The MACD of 5.42 indicates Positive momentum. The RSI at 54.70 is Neutral, neither overbought nor oversold. The STOCH value of 87.62 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:AURA.

Aura Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IL:AURA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IL:SMTIL:SMT77OutperformILS 2.70B5.25―10.77%64.49%132.97%
IL:ARGOIL:ARGO63NeutralILS 3.07B10.35――37.38%35.54%
IL:AFPRIL:AFPR59NeutralILS 7.48B6.73――3.34%44.21%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IL:AURAIL:AURA55NeutralILS 5.08B19.02―1.07%47.76%-2.38%
IL:ELCREIL:ELCRE38UnderperformILS 1.24B-5.76――5.23%29.87%

* General Sector Average

Performance Comparison

-50%-25%0%25%IL:AURAIL:SMTIL:AFPRIL:ELCREIL:BLSRIL:ARGODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IL:AURA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IL:AURAAura Investments Limited1810.00-335.47-15.64%
IL:SMTSummit Real Estate Holdings Ltd3897.00-2748.00-41.35%
IL:AFPRAFI Properties Ltd18170.00-3430.00-15.88%
IL:ELCREElectra Real Estate Ltd.1411.00-2918.69-67.41%
IL:BLSRBlue Square Real Estate Ltd29330.00-9959.73-25.35%
IL:ARGOArgo Properties NV12800.00260.002.07%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026